MERITAGE PORTFOLIO MANAGEMENT - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MERITAGE PORTFOLIO MANAGEMENT ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q1 2015$7,334,000
+71.2%
189,125
+48.7%
0.74%
+61.8%
Q4 2014$4,284,000
-4.0%
127,225
-0.1%
0.46%
-10.4%
Q3 2014$4,461,000127,3850.51%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders